| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Pubmed | 6.56e-07 | 209 | 28 | 5 | 36779422 | ||
| Pubmed | 9.44e-07 | 225 | 28 | 5 | 12168954 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 31614206 | ||
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 22899851 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 5.21e-05 | 857 | 28 | 6 | 25609649 | |
| Pubmed | 6.52e-05 | 15 | 28 | 2 | 18541383 | ||
| Pubmed | Betaglycan is required for the establishment of nephron endowment in the mouse. | 6.52e-05 | 15 | 28 | 2 | 21533152 | |
| Pubmed | Abrogation of Eya1/Six1 disrupts the saccular phase of lung morphogenesis and causes remodeling. | 8.44e-05 | 17 | 28 | 2 | 23895934 | |
| Pubmed | 1.11e-04 | 116 | 28 | 3 | 30804394 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 1.49e-04 | 1038 | 28 | 6 | 26673895 | |
| Pubmed | 1.85e-04 | 25 | 28 | 2 | 20019329 | ||
| Pubmed | 3.35e-04 | 418 | 28 | 4 | 34709266 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 5.63e-04 | 861 | 28 | 5 | 36931259 | |
| Pubmed | 6.90e-04 | 216 | 28 | 3 | 31519766 | ||
| Pubmed | 7.18e-04 | 49 | 28 | 2 | 31762063 | ||
| Pubmed | 7.18e-04 | 219 | 28 | 3 | 29997244 | ||
| Interaction | GSK3B interactions | 1.65e-05 | 868 | 28 | 8 | int:GSK3B | |
| Cytoband | 7p22.1 | 3.81e-04 | 47 | 28 | 2 | 7p22.1 | |
| Cytoband | 2p23.3 | 7.97e-04 | 68 | 28 | 2 | 2p23.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p22 | 3.04e-03 | 134 | 28 | 2 | chr7p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p23 | 3.74e-03 | 149 | 28 | 2 | chr2p23 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.80e-02 | 718 | 17 | 3 | 28 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 177 | 28 | 3 | 1b153fbfe1323dc589de4af73a52149ea5ce6763 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.82e-04 | 177 | 28 | 3 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 177 | 28 | 3 | 32fecefba1a55e1f418c9a055236fa11175c692d | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.82e-04 | 177 | 28 | 3 | a68c3688f12aee22f3cb4049c4bccacbacb0fae6 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-04 | 177 | 28 | 3 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-04 | 178 | 28 | 3 | 731e1e8eff2c4018c75dfc66632a316010a09a9a | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.89e-04 | 179 | 28 | 3 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-04 | 181 | 28 | 3 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.98e-04 | 182 | 28 | 3 | 14a117c5e50db31ee1b2cf4df4d133451fd6d55f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-04 | 183 | 28 | 3 | 38a54216458ad57f356bb4ddf272e1af8036ddeb | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-04 | 183 | 28 | 3 | 764ea07621f77fbd13a877aed5806ae2b3dfb43e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.11e-04 | 186 | 28 | 3 | bdbe290f81106a53c8c30a92fbb385597c62b2ac | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-04 | 187 | 28 | 3 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.18e-04 | 188 | 28 | 3 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-04 | 188 | 28 | 3 | c300accbac71a3bc075fe985543d8a8ead82531b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.18e-04 | 188 | 28 | 3 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.18e-04 | 188 | 28 | 3 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.18e-04 | 188 | 28 | 3 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.21e-04 | 189 | 28 | 3 | 7dad62bd50c197838058e89abd0ee387de3e83cd | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 189 | 28 | 3 | 319e42f6e2322208de78bc666fb2c074707eb4da | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 190 | 28 | 3 | 050d6e0546954675b6adbfecb67854b1e09739d1 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.39e-04 | 194 | 28 | 3 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.42e-04 | 195 | 28 | 3 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.50e-04 | 197 | 28 | 3 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | mild-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.50e-04 | 197 | 28 | 3 | 0cb00daa6943f7a7fb34a8fdf51188646af65686 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.54e-04 | 198 | 28 | 3 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 2.57e-04 | 199 | 28 | 3 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 28 | 3 | c89f3cb36bb14c476d6a392bfd3ded1c8feecfeb | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 28 | 3 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 28 | 3 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Neuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.61e-04 | 200 | 28 | 3 | 4409065bc7aa995354c71e0f9d6f3726cf393d6b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Intermediate|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.61e-04 | 200 | 28 | 3 | e5a8647c47a49c8c90c78d681193946de103d8ff | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 1.93e-06 | 171 | 28 | 5 | 7535_DN | |
| Disease | polyp of colon | 1.12e-03 | 56 | 26 | 2 | MONDO_0021400 | |
| Disease | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis | 1.74e-03 | 70 | 26 | 2 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0001060, EFO_0002609, EFO_0003898, EFO_0005140, EFO_0006812, MONDO_0005147, MONDO_0007915, MONDO_0015517 | |
| Disease | Corneal astigmatism | 2.10e-03 | 77 | 26 | 2 | EFO_1002040 | |
| Disease | central corneal thickness | 2.47e-03 | 309 | 26 | 3 | EFO_0005213 | |
| Disease | mean corpuscular hemoglobin concentration | 2.49e-03 | 1105 | 26 | 5 | EFO_0004528 | |
| Disease | S-warfarin measurement | 3.30e-03 | 97 | 26 | 2 | EFO_0803323 | |
| Disease | migraine disorder | 3.71e-03 | 357 | 26 | 3 | MONDO_0005277 | |
| Disease | corneal topography | 4.15e-03 | 109 | 26 | 2 | EFO_0004345 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MEESELHEVLHHTLT | 1006 | Q9P2K8 | |
| ELSNHHDHHDEFCLM | 96 | Q00994 | |
| LAHELGHVLSMPHDD | 361 | Q9UP79 | |
| RAMHSLHSQLHDLSL | 636 | Q96QP1 | |
| VSEEELIHHLLMHGL | 756 | Q6IQ32 | |
| LAEAEMHVHHLESLL | 336 | Q8IUD2 | |
| HTFDNMLHLHSLSLE | 971 | Q6ZRR7 | |
| FHHHKLTLADMDRIL | 456 | P0C881 | |
| FHHHKLTLADMDRIL | 456 | B2RC85 | |
| LEASMHSVLSDLHEA | 46 | Q14118 | |
| SHSDLMALHHALELE | 576 | Q99502 | |
| LANMEHSFHHILLLE | 316 | Q14D04 | |
| NDLLSHSGMLDHSHS | 1006 | Q9ULH7 | |
| HSDIVMATLHELLHA | 296 | A0A1B0GTW7 | |
| LAHIIHHLAAISLMS | 206 | Q8IU89 | |
| SHDSIKMEIVDHALH | 481 | O60716 | |
| LMHHLTEDHLDLNNA | 281 | Q14814 | |
| TLKDHIMSHPALHDA | 136 | Q9NUP7 | |
| DHIHVHFKDIALMDD | 946 | P57071 | |
| DILDDEMPHHDLHSV | 476 | Q68CZ2 | |
| LHSKAEQHLMCEEHE | 116 | Q9BYV2 | |
| TMLHRASLFDHHELA | 311 | O75762 | |
| EHTSHLEAELEKHMA | 1196 | Q9P2E9 | |
| DLHSHHELRAMELCE | 96 | P84022 | |
| TLDHLHLKMCSLHDH | 546 | Q9UJT2 | |
| HAVDAHLLHASALDL | 56 | Q5BKY6 | |
| LAHSLAIMTDAAHLL | 96 | Q99726 | |
| HIADNSKDLESHMIH | 676 | Q8TCN5 | |
| EDLMSLLDADIHSAH | 246 | O95071 | |
| RLHHFNSSHLEIDDM | 341 | Q6NSJ0 |